Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700023576

Trial Profile

Clinical Trials Insight: 700023576

Phase of Trial: Phase II

Latest Information Update: 18 May 2010

At a glance

  • Drugs Taberminogene vadenovec (Primary)
  • Indications Thrombosis
  • Focus Therapeutic Use
  • Sponsors Ark Therapeutics
  • Most Recent Events

    • 18 May 2010 Following a strategic review, work has begun to modify the existing Trinam phase III trial to a phase IIb trial according to an Ark Therapeutics media release.
    • 18 May 2010 Recruitment into the revised trial is being driven hard and the results from the trial are expected in mid-2011 according to an Ark Therapeutics media release.
    • 16 May 2008 This trial is expected to begin by mid 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top